This article was originally published in The Gray Sheet
U.S. Postal Service selects Cepheid's GeneXpert system for inclusion in initial $3.7 mil. pilot program evaluating the use of DNA-based tests for bio-threat detection. Based on results of the pilot, USPS plans to grant a multi-million dollar contract by the end of September to install DNA-based detection systems in all of its approximately 300 automatic mail-sorting facilities in the U.S. Of the initial program funding, Cepheid will receive about $750,000...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.